Both T1DM and T2DM FreeStyle Libre users spent significantly less time in hypoglycemia(70 mg/dl)16.
1 hour increase in Time in Range in persons with diabetes on the FreeStyle Libre system16.
66% reduction in hospital admissions with the FreeStyle Libre system over 1 year17.
58% reduction in work absenteeism17.
95% report a better understanding of his or her glucose fluctuation17.
92% find it easier to regulate glucose around a meal17.
16. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.
17. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care 2019;7:e000809. doi:10.1136/bmjdrc-2019-000809.
ADC-28471 v1.0 10/20
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
FreeStyle.abbott/in-en is a product-specific website intended for residents of India only. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.